Charles Z. Ding
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Z. Ding.
Bioorganic & Medicinal Chemistry Letters | 2000
Charles Z. Ding; John T. Hunt; Carol Ricca; Veeraswamy Manne
Design, synthesis and structure-activity relationship of a series of 3-imidazolylmethylaminophenylsulfonyltetrahydroquinolines as farnesyltransferase inhibitors are presented. A working pharmacophore of inhibiting farnesyltransferase by this series of inhibitors is proposed.
Tetrahedron Letters | 1996
Charles Z. Ding
Abstract β-Aryl-β-aminoalcohols (1) were prepared from N-diphenylmethylene benzylamines (2) diastereoselectively in a one-pot procedure.
Synthetic Communications | 1996
Charles Z. Ding
Abstract Various 2,2-dimethyl-6-functional-2H-1-benzopyrans were prepared via a halogen-metal exchange reaction followed by treatment with electrophiles. These 6-functionalized chromenes are important synthetic intermediates for preparation of benzopyran-based potassium channel openers.
Tetrahedron Letters | 1996
Charles Z. Ding; Arthur V. Miller
Abstract Various heteroaryls were found to undergo 1,4-oxygen to nitrogen migration (e.g. 4→1 ) under acidic conditions. This unprecedented migratin provides a convenient access to 4-(N-alkyl-N-heteroaryl)amino-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile derivatives, which are otherwise difficult to prepare.
Bioorganic & Medicinal Chemistry Letters | 2015
Hao Zhang; Charles Z. Ding; Zhi Lai; Sean S. Chen; Pratik Devasthale; Tim Herpin; George C. Morton; Fucheng Qu; Denis E. Ryono; Rebecca A. Smirk; Wei Wang; Shung Wu; Xiang-Xang Ye; Yi-Xin Li; Atsu Apedo; Dennis Farrelly; Tao Wang; Liqun Gu; Nathan Morgan; Neil Flynn; Cuixia Chu; Lori Kunselman; Jonathan Lippy; Kenneth T. Locke; Kevin O’Malley; Thomas Harrity; Michael Cap; Lisa Zhang; Vinayak Hosagrahara; Pathanjali Kadiyala
The design, synthesis and structure-activity relationships of a novel series of 3,4-disubstituted pyrrolidine acid analogs as PPAR ligands is outlined. In both the 1,3- and 1,4-oxybenzyl pyrrolidine acid series, the preferred stereochemistry was shown to be the cis-3R,4S isomer, as exemplified by the potent dual PPARα/γ agonists 3k and 4i. The N-4-trifluoromethyl-pyrimidinyl pyrrolidine acid analog 4i was efficacious in lowering fasting glucose and triglyceride levels in diabetic db/db mice.
Archive | 1997
Rajeev S. Bhide; Charles Z. Ding; John T. Hunt; Soong-Hoon Kim; Katerina Leftheris
Journal of Medicinal Chemistry | 2000
John T. Hunt; Charles Z. Ding; Roberta Batorsky; Mark S. Bednarz; Rajeev S. Bhide; Young H. Cho; Saeho Chong; Sam T. Chao; Johnni Gullo-Brown; Peng Guo; Soong Hoon Kim; Francis Y. Lee; Katerina Leftheris; Arthur V. Miller; Toomas Mitt; Manorama Patel; Becky Penhallow; Carol Ricca; William C. Rose; Robert J. Schmidt; William Allen Slusarchyk; Gregory D. Vite; Veeraswamy Manne
Journal of Medicinal Chemistry | 1997
George C. Rovnyak; Syed Z. Ahmed; Charles Z. Ding; Steven Dzwonczyk; Francis N. Ferrara; W. Griffith Humphreys; Gary J. Grover; Dinos Santafianos; Karnail S. Atwal; Anne J. Baird; Lee G. McLaughlin; Diane E. Normandin; and Paul G. Sleph; Sarah C. Traeger
Archive | 1993
Karnail S. Atwal; Francis N. Ferrara; Charles Z. Ding
Archive | 1997
Charles Z. Ding